NCAM1 and neoplasm: Ex-vivo expanded human CD3+CD56+ CIK cells produce cytokines of the TH1 type and have broad non-MHC-restricted cytotoxicity against a variety of tumor cell lines as well as autologous and allogeneic fresh tumor isolates [3,6,7,8,12,17,23,36].